IN-VIVO METABOLISM AND DISPOSITION OF A NEW ANTICANCER PARP INHIBITOR BMN 673 IN RAT AND DOG

被引：0
|
作者：
Musson, Donald
Musson, Donald G.
Haroldsen, Peter
Oppeneer, Todd
Bashir, Mohammed
O'Neill, Charles
机构：
来源：
DRUG METABOLISM REVIEWS | 2012年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：126 / 127
页数：2
相关论文
共 50 条
  • [31] Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
    Arjun Mittra
    Geraldine H. O’ Sullivan Coyne
    Jennifer Zlott
    Shivaani Kummar
    Robert Meehan
    Lawrence Rubinstein
    Lamin Juwara
    Deborah Wilsker
    Jiuping Ji
    Brandon Miller
    Tony Navas
    Katherine V. Ferry-Galow
    Andrea Regier Voth
    Ting-Chia Chang
    Shahanawaz Jiwani
    Ralph E. Parchment
    James H. Doroshow
    Alice P. Chen
    Cancer Chemotherapy and Pharmacology, 2024, 93 : 177 - 189
  • [32] RESULTS OF A PHASE 1 STUDY OF BMN 673, A POTENT AND SPECIFIC PARP-1/2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES
    Mufti, G. J.
    Estey, E.
    Popat, R.
    Mattison, R.
    Menne, T.
    Azar, J.
    Bloor, A.
    Gaymes, T.
    Khwaja, A.
    Juckett, M.
    Lennard, A.
    Zhang, C.
    Gallant, G. J. A.
    Gopal, A. K.
    HAEMATOLOGICA, 2014, 99 : 33 - 34
  • [33] IN-VIVO BIOTRANSFORMATION OF FENOCTIMINE IN RAT, DOG AND MAN
    WU, WN
    HILLS, JF
    CHANG, SY
    XENOBIOTICA, 1994, 24 (11) : 1133 - 1148
  • [34] Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
    Mittra, Arjun
    Coyne, Geraldine H. O' Sullivan
    Zlott, Jennifer
    Kummar, Shivaani
    Meehan, Robert
    Rubinstein, Lawrence
    Juwara, Lamin
    Wilsker, Deborah
    Ji, Jiuping
    Miller, Brandon
    Navas, Tony
    Ferry-Galow, Katherine V.
    Voth, Andrea Regier
    Chang, Ting-Chia
    Jiwani, Shahanawaz
    Parchment, Ralph E.
    Doroshow, James H.
    Chen, Alice P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (03) : 177 - 189
  • [35] IN-VIVO METABOLISM OF SALATRIM FATS IN THE RAT
    HAYES, JR
    FINLEY, JW
    LEVEILLE, GA
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1994, 42 (02) : 500 - 514
  • [36] IN-VIVO STABILITY, DISPOSITION AND METABOLISM OF A HYBRID OLIGONUCLEOTIDE PHOSPHOROTHIOATE IN RATS
    ZHANG, RW
    LU, ZH
    ZHAO, H
    ZHANG, XS
    DIASIO, RB
    HABUS, I
    JIANG, ZW
    IYER, RP
    YU, D
    AGRAWAL, S
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) : 545 - 556
  • [37] Pharmacokinetics and metabolism of a new phosphodiesterase V inhibitor yonkenafil in rat and dog
    Fawcet, J. Paul
    Mikov, Momir
    Wang, Jian
    Gu, Jingkai
    DRUG METABOLISM REVIEWS, 2006, 38 : 134 - 135
  • [38] Pediatric Preclinical Testing Program (PPTP) evaluation of BMN 673, an inhibitor of Poly-ADP Ribose Polymerase (PARP), alone and with Temozolomide (TMZ).
    Smith, Malcolm
    Kang, Min
    Reynolds, Patrick
    Gorlick, Richard
    Kolb, Anders
    Maris, John
    Lock, Richard
    Carol, Hernan
    Keir, Stephen
    Billups, Catherine
    Kurmasheva, Raushan
    Houghton, Peter
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [39] THE METABOLISM AND DISPOSITION OF FENOFIBRATE IN RAT, GUINEA-PIG, AND DOG
    WEIL, A
    CALDWELL, J
    STROLINBENEDETTI, M
    DRUG METABOLISM AND DISPOSITION, 1988, 16 (02) : 302 - 309
  • [40] Influence of pentobarbitone on in-vivo local disposition of diclofenac in rat liver
    Tabata, K
    Yamaoka, K
    Yasui, H
    Fukuyama, T
    Nakagawa, T
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (08) : 866 - 869
12345